Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Bonti
3197
Bonti
Technology
Biotechnology
Bonti is a rapidly emerging biotech company. Our lead product candidate is EB001, is used for both Therapeutic & Aesthetic needs.
Suggest edits
Type
B2c
Founded
2015
Raised
$27.2M
Follow us
Companies in the same industry
Magellan Health Services
Neurocrine Biosciences
Lucigen
Twinstrand Therapeutics
BioConference Live
Immunomic Therapeutics
Resverlogix Corp.
Smart Energy
Isogenica
KIYATEC
Alexa global traffic share
Overview
Funding
2
Add info
Add round
23 Jan
2018
$15,500,000
Venture capital (Series C)
Former Botox Bosses Raise $15.5 Million for Biotech Startup Bonti
VentureWire
+1
19 Apr
2017
$11,700,000
Venture capital (Series B)
City Hill Ventures
,
Colt Ventures
,
RBV Capital
Bonti Raises $11.7 Million in an Oversubscribed Series B Financing to Advance Development of Lead Product EB-001
businesswire
